Zscaler (ZS) 10-Q 6 Mar 24 2024 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jan. 31, 2024	Feb. 29, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jan. 31, 2024
Document Transition Report	false
Entity File Number	001-38413
Entity Registrant Name	ZSCALER, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1173892
Entity Address, Address Line One	120 Holger Way
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95134
City Area Code	408
Local Phone Number	533-0288
Title of 12(b) Security	Common Stock, $0.001 Par Value
Trading Symbol	ZS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Shares Outstanding		149,857,976
Entity Central Index Key	0001713683
Current Fiscal Year End Date	--07-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 31, 2024	Jul. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,438,586	$ 1,262,206
Short-term investments	1,021,218	838,026
Accounts receivable, net	479,611	582,636
Deferred contract acquisition costs	125,591	115,827
Prepaid expenses and other current assets	77,702	91,619
Total current assets	3,142,708	2,890,314
Property and equipment, net	294,495	242,355
Operating lease right-of-use assets	87,804	70,671
Deferred contract acquisition costs, noncurrent	255,883	259,407
Acquired intangible assets, net	22,540	25,859
Goodwill	92,415	89,192
Other noncurrent assets	38,381	30,519
Total assets	3,934,226	3,608,317
Current liabilities:
Accounts payable	17,137	18,481
Accrued expenses and other current liabilities	68,217	64,975
Accrued compensation	137,362	136,800
Deferred revenue	1,316,416	1,281,143
Operating lease liabilities	44,773	34,469
Total current liabilities	1,583,905	1,535,868
Convertible senior notes, net	1,141,011	1,134,159
Deferred revenue, noncurrent	185,759	158,533
Operating lease liabilities, noncurrent	47,906	41,917
Other noncurrent liabilities	16,789	12,728
Total liabilities	2,975,370	2,883,205
Commitments and contingencies (Note 10)
Stockholders’ Equity
Common stock; $0.001 par value; 1,000,000 shares authorized as of January 31, 2024 and July 31, 2023; 149,758 and 147,169 shares issued and outstanding as of January 31, 2024 and July 31, 2023, respectively	150	147
Additional paid-in capital	2,114,041	1,816,915
Accumulated other comprehensive loss	(3,009)	(1,576)
Accumulated deficit	(1,152,326)	(1,090,374)
Total stockholders’ equity	958,856	725,112
Total liabilities and stockholders’ equity	$ 3,934,226	$ 3,608,317

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jan. 31, 2024	Jul. 31, 2023
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	149,758,000	147,169,000
Common stock, shares outstanding (in shares)	149,758,000	147,169,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Income Statement [Abstract]
Revenue	$ 524,999	$ 387,598	$ 1,021,702	$ 743,146
Cost of revenue	117,199	87,604	228,593	164,301
Gross profit	407,800	299,994	793,109	578,845
Operating expenses:
Sales and marketing	276,481	235,945	543,592	464,781
Research and development	122,181	85,765	235,720	160,711
General and administrative	54,595	43,522	105,311	87,678
Total operating expenses	453,257	365,232	884,623	713,170
Loss from operations	(45,457)	(65,238)	(91,514)	(134,325)
Interest income	28,385	12,669	54,327	20,534
Interest expense	(3,605)	(1,333)	(6,764)	(2,664)
Other income (expense), net	172	141	(1,040)	(722)
Loss before income taxes	(20,505)	(53,761)	(44,991)	(117,177)
Provision for income taxes	7,964	3,692	16,961	8,438
Net loss	$ (28,469)	$ (57,453)	$ (61,952)	$ (125,615)
Net loss per share, basic (in dollars per share)	$ (0.19)	$ (0.40)	$ (0.42)	$ (0.87)
Net loss per share, diluted (in dollars per share)	$ (0.19)	$ (0.40)	$ (0.42)	$ (0.87)
Weighted-average shares used in computing net loss per share, basic (in shares)	148,951	144,511	148,287	144,001
Weighted-average shares used in computing net loss per share, diluted (in shares)	148,951	144,511	148,287	144,001

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (28,469)	$ (57,453)	$ (61,952)	$ (125,615)
Available-for-sale securities:
Change in net unrealized gains on available-for-sale securities	9,204	4,501	8,615	1,853
Cash flow hedging instruments:
Change in net unrealized gains (losses)	7,353	24,019	(7,783)	9,980
Net realized (gains) losses reclassified into net loss	(1,611)	4,267	(2,265)	8,980
Net change on cash flow hedges	5,742	28,286	(10,048)	18,960
Other comprehensive income (loss)	14,946	32,787	(1,433)	20,813
Comprehensive loss	$ (13,523)	$ (24,666)	$ (63,385)	$ (104,802)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jul. 31, 2022			143,038
Beginning balance at Jul. 31, 2022	$ 573,300	$ (169,899)	$ 143	$ 1,590,885	$ (273,738)	$ (25,850)	$ (991,878)	$ 103,839
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			224
Issuance of common stock upon exercise of stock options	2,104			2,104
Issuance of common stock under the employee stock purchase plan (in shares)			115
Issuance of common stock under the employee stock purchase plan	11,410			11,410
Vesting of restricted stock units and other stock issuances (in shares)			1,710
Vesting of restricted stock units and other stock issuances	0		$ 2	(2)
Stock-based compensation	216,544			216,544
Other comprehensive income (loss)	20,813					20,813
Net loss	(125,615)						(125,615)
Ending balance (in shares) at Jan. 31, 2023			145,087
Ending balance at Jan. 31, 2023	528,657		$ 145	1,547,203		(5,037)	(1,013,654)
Beginning balance (in shares) at Oct. 31, 2022			144,210
Beginning balance at Oct. 31, 2022	431,275		$ 144	1,425,156		(37,824)	(956,201)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			115
Issuance of common stock upon exercise of stock options	1,122			1,122
Issuance of common stock under the employee stock purchase plan (in shares)			115
Issuance of common stock under the employee stock purchase plan	11,410			11,410
Vesting of restricted stock units and other stock issuances (in shares)			647
Vesting of restricted stock units and other stock issuances	0		$ 1	(1)
Stock-based compensation	109,516			109,516
Other comprehensive income (loss)	32,787					32,787
Net loss	(57,453)						(57,453)
Ending balance (in shares) at Jan. 31, 2023			145,087
Ending balance at Jan. 31, 2023	$ 528,657		$ 145	1,547,203		(5,037)	(1,013,654)
Beginning balance (in shares) at Jul. 31, 2023	147,169		147,169
Beginning balance at Jul. 31, 2023	$ 725,112		$ 147	1,816,915		(1,576)	(1,090,374)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	468		468
Issuance of common stock upon exercise of stock options	$ 3,848			3,848
Issuance of common stock under the employee stock purchase plan (in shares)			176
Issuance of common stock under the employee stock purchase plan	18,407			18,407
Vesting of restricted stock units and other stock issuances (in shares)			1,945
Vesting of restricted stock units and other stock issuances	0		$ 3	(3)
Stock-based compensation	274,874			274,874
Other comprehensive income (loss)	(1,433)					(1,433)
Net loss	$ (61,952)						(61,952)
Ending balance (in shares) at Jan. 31, 2024	149,758		149,758
Ending balance at Jan. 31, 2024	$ 958,856		$ 150	2,114,041		(3,009)	(1,152,326)
Beginning balance (in shares) at Oct. 31, 2023			148,313
Beginning balance at Oct. 31, 2023	807,525		$ 148	1,949,189		(17,955)	(1,123,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			317
Issuance of common stock upon exercise of stock options	2,592			2,592
Issuance of common stock under the employee stock purchase plan (in shares)			176
Issuance of common stock under the employee stock purchase plan	18,407			18,407
Vesting of restricted stock units and other stock issuances (in shares)			952
Vesting of restricted stock units and other stock issuances	0		$ 2	(2)
Stock-based compensation	143,855			143,855
Other comprehensive income (loss)	14,946					14,946
Net loss	$ (28,469)						(28,469)
Ending balance (in shares) at Jan. 31, 2024	149,758		149,758
Ending balance at Jan. 31, 2024	$ 958,856		$ 150	$ 2,114,041		$ (3,009)	$ (1,152,326)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Cash Flows From Operating Activities
Net loss	$ (61,952)	$ (125,615)
Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation and amortization expense	29,361	25,241
Amortization expense of acquired intangible assets	6,119	5,103
Amortization of deferred contract acquisition costs	61,504	46,053
Amortization of debt issuance costs	1,955	1,945
Non-cash operating lease costs	21,633	14,988
Stock-based compensation expense	269,570	214,911
Accretion of investments purchased at a discount	(9,582)	(1,433)
Unrealized (gains) losses on hedging transactions	2,841	(696)
Deferred income taxes	(1,437)	9
Other	1,403	(784)
Changes in operating assets and liabilities, net of effects of business combinations
Accounts receivable	102,374	40,800
Deferred contract acquisition costs	(67,744)	(64,202)
Prepaid expenses, other current and noncurrent assets	2,660	(7,800)
Accounts payable	(2,412)	5,228
Accrued expenses, other current and noncurrent liabilities	6,020	5,899
Accrued compensation	562	(17,651)
Deferred revenue	62,477	90,862
Operating lease liabilities	(22,477)	(14,920)
Net cash provided by operating activities	402,875	217,938
Cash Flows From Investing Activities
Purchases of property, equipment and other assets	(59,553)	(43,883)
Capitalized internal-use software	(17,816)	(15,623)
Payments for business acquisitions, net of cash acquired	(4,377)	0
Purchase of strategic investments	(2,000)	(1,200)
Purchases of short-term investments	(761,796)	(513,743)
Proceeds from maturities of short-term investments	594,687	586,801
Proceeds from sale of short-term investments	2,105	0
Net cash provided by (used in) investing activities	(248,750)	12,352
Cash Flows From Financing Activities
Proceeds from issuance of common stock upon exercise of stock options	3,848	2,104
Proceeds from issuance of common stock under the employee stock purchase plan	18,407	11,410
Other	0	(2)
Net cash provided by financing activities	22,255	13,512
Net increase in cash and cash equivalents	176,380	243,802
Cash and cash equivalents at beginning of period	1,262,206	1,013,210
Cash and cash equivalents at end of period	1,438,586	1,257,012
Supplemental Disclosure of Cash Flow Information
Cash paid for income taxes, net of tax refunds	11,509	3,008
Cash paid for interest expense	718	719
Non-Cash Activities
Operating lease right-of-use assets obtained in exchange for operating lease obligations, net of terminations	37,081	12,136
Net change in purchased equipment included in accounts payable and accrued expenses	$ 2,130	$ 2,839

Business and Summary of Signifi

Business and Summary of Significant Accounting Policies	6 Months Ended
	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business and Summary of Significant Accounting Policies	Business and Summary of Significant Accounting Policies Description of the Business Zscaler, Inc. ("Zscaler," the "Company," "we," "us," or "our") is a cloud security company that developed a platform incorporating core security functionalities needed to enable fast and secure access to cloud resources based on identity, context and organization’s policies. Our solution is a purpose-built, multi-tenant, distributed cloud platform that incorporates the security functionality needed to enable users, applications, and devices to safely and efficiently utilize authorized applications and services based on an organization’s business policies. We deliver our solutions using a software-as-a-service ("SaaS") business model and sell subscriptions to customers to access our cloud platform, together with related support services. We were incorporated in Delaware in September 2007 and conduct business worldwide, with presence in North America, Europe and Asia. Our headquarters are in San Jose, California. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") and applicable regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the applicable required disclosures and regulations of the SEC. Therefore, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's audited consolidated financial statements and related notes in its Annual Report on Form 10-K for the fiscal year ended July 31, 2023 (the "Fiscal 2023 Form 10-K"), as filed with the SEC on September 14, 2023. Interim Unaudited Condensed Consolidated Financial Statements The accompanying condensed consolidated balance sheet as of July 31, 2023 was derived from the audited consolidated financial statements as of that date. The accompanying interim unaudited condensed consolidated financial statements, including the condensed consolidated balance sheet as of January 31, 2024, the condensed consolidated statements of operations for the three and six months ended January 31, 2024 and 2023, the condensed consolidated statements of comprehensive loss for the three and six months ended January 31, 2024 and 2023, the condensed consolidated statements of stockholders’ equity for the three and six months ended January 31, 2024 and 2023 and the condensed consolidated statements of cash flows for the six months ended January 31, 2024 and 2023 are unaudited. The related financial data and the other financial information disclosed in the accompanying notes to these interim unaudited condensed consolidated financial statements are also unaudited. These interim unaudited condensed consolidated financial statements have been prepared on a basis consistent with our annual consolidated financial statements and, in our opinion, include all normal recurring adjustments necessary to state fairly our quarterly results. The results of operations for the three and six months ended January 31, 2024 are not necessarily indicative of the results to be expected for our fiscal year ending July 31, 2024 or for any other future fiscal year or interim period. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal-use software, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the condensed consolidated financial statements. Due to uncertainty in the macroeconomic environment, including but not limited to the effects of inflation, and geopolitical events, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained . In August 2023, we completed an assessment of the useful lives of our servers and networking equipment, which resulted in an extension of their useful lives from four Fiscal Year Our fiscal year ends on July 31. References to fiscal 2024, for example, refer to our fiscal year ending July 31, 2024. Significant Accounting Polici es Our significant accounting policies are described in the Fiscal 2023 Form 10-K. There have been no significant changes to these policies that have had a material impact on the condensed consolidated financial statements and related notes for the three and six months ended January 31, 2024. Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU No. 2023-07, Segment Reporting (Topic 280 ): Improvements to Reportable Segment Disclosures , which requires disclosure of incremental segment information on an annual and interim basis. Th is standard is effective for us in the first quarter of fiscal 2025. We are currently evaluating the potential impact of this standard. In December 2023, the FASB issued 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amended guidance enhances income tax disclosures primarily related to the effective tax rate reconciliation and income taxes paid information. This guidance requires disclosures of specific categories in the effective tax rate reconciliation and further information on reconciling items meeting a quantitative threshold. In addition, the amended guidance requires disaggregating income taxes paid (net of refunds received) by federal, state and foreign taxes. It also requires disaggregating individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 % of total income taxes paid (net of refunds received). Th

Revenue Recognition

Revenue Recognition	6 Months Ended
	Jan. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue Subscription and support revenue is recognized over time and accounted for approximately 97% of our revenue for each of the three and six months ended January 31, 2024 and 2023, respectively. The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use our cloud platform: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 Amount % Revenue Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except for percentage data) United States $ 263,970 50 % $ 193,508 50 % $ 511,502 50 % $ 369,023 50 % Europe, Middle East and Africa 164,009 31 % 124,742 32 % 321,254 31 % 241,749 32 % Asia Pacific 79,077 15 % 57,602 15 % 154,157 15 % 109,858 15 % Other 17,943 4 % 11,746 3 % 34,789 4 % 22,516 3 % Total $ 524,999 100 % $ 387,598 100 % $ 1,021,702 100 % $ 743,146 100 % The following table summarizes the revenue from contracts by type of customer: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 Amount % Revenue Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except for percentage data) Channel partners $ 480,592 92 % $ 358,165 92 % $ 935,047 92 % $ 687,522 93 % Direct customers 44,407 8 % 29,433 8 % 86,655 8 % 55,624 7 % Total $ 524,999 100 % $ 387,598 100 % $ 1,021,702 100 % $ 743,146 100 % Significant Customers No single customer accounted for 10% or more of the total revenue or the total balance of accounts receivable, net in the periods presented. Contract Balances Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are recognized as revenue over the contractual period. Deferred revenue, including current and noncurrent balances, as of January 31, 2024 and July 31, 2023 was $1,502.2 million and $1,439.7 million, respectively. In the six months ended January 31, 2024 and 2023, we recognized revenue of $840.8 million and $603.8 million, respectively, that was included in the corresponding contract liability balance at the beginning of these periods. Remaining Performance Obligations The typical subscription and support term is one Costs to Obtain and Fulfill a Contract We capitalize sales commission and associated payroll taxes paid to sales personnel that are incremental to the acquisition of channel partner and direct customer contracts. These costs are recorded as deferred contract acquisition costs in the condensed consolidated balance sheets. The activity of the deferred contract acquisition costs consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 (in thousands) Beginning balance $ 372,803 $ 301,472 $ 375,234 $ 297,002 Capitalization of contract acquisition costs 40,064 37,407 67,744 64,202 Amortization of deferred contract acquisition costs (31,393) (23,728) (61,504) (46,053) Ending balance $ 381,474 $ 315,151 $ 381,474 $ 315,151 The outstanding balance of the deferred contract acquisition costs consisted of the following: January 31, 2024 July 31, 2023 (in thousands) Deferred contract acquisition costs, current $ 125,591 $ 115,827 Deferred contract acquisition costs, noncurrent 255,883 259,407 Total deferred contract acquisition costs $ 381,474 $ 375,234 Sales commissions accrued but not paid as of January 31, 2024 and July 31, 2023, totaled $24.3 million and $48.0 million, respectively, which are included within accrued compensation in the condensed consolidated balance sheets.

Cash Equivalents and Short-Term

Cash Equivalents and Short-Term Investments	6 Months Ended
	Jan. 31, 2024
Cash and Cash Equivalents [Abstract]
Cash Equivalents and Short-Term Investments	Cash Equivalents and Short-Term Investments Cash equivalents and short-term investments consisted of the following as of January 31, 2024: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 884,888 $ — $ — $ 884,888 U.S. treasury securities 148,846 — (24) 148,822 U.S. government agency securities 218,975 — (30) 218,945 Corporate debt securities 16,497 — — 16,497 Total cash equivalents $ 1,269,206 $ — $ (54) $ 1,269,152 Short-term investments: U.S. treasury securities $ 311,785 $ 88 $ (532) $ 311,341 U.S. government agency securities 150,437 109 (1,638) 148,908 Corporate debt securities 560,726 1,600 (1,357) 560,969 Total short-term investments $ 1,022,948 $ 1,797 $ (3,527) $ 1,021,218 Total cash equivalents and short-term investments $ 2,292,154 $ 1,797 $ (3,581) $ 2,290,370 Cash equivalents and short-term investments consisted of the following as of July 31, 2023: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 768,003 $ — $ — $ 768,003 U.S. treasury securities 157,250 — (30) 157,220 U.S. government agency securities 166,671 — (35) 166,636 Corporate debt securities 38,800 — — 38,800 Total cash equivalents $ 1,130,724 $ — $ (65) $ 1,130,659 Short-term investments: U.S. treasury securities $ 175,451 $ — $ (1,875) $ 173,576 U.S. government agency securities 266,392 2 (4,299) 262,095 Corporate debt securities 406,517 49 (4,211) 402,355 Total short-term investments $ 848,360 $ 51 $ (10,385) $ 838,026 Total cash equivalents and short-term investments $ 1,979,084 $ 51 $ (10,450) $ 1,968,685 The amortized cost and fair value of our short-term investments based on their stated maturities consisted of the following as of January 31, 2024: Amortized Fair Value (in thousands) Due within one year $ 575,536 $ 572,868 Due between one to three years 447,412 448,350 Total $ 1,022,948 $ 1,021,218 Short-term investments that were in an unrealized loss position as of January 31, 2024 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 242,238 $ (532) $ — $ — $ 242,238 $ (532) U.S. government agency securities 68,954 (57) 53,831 (1,581) 122,785 (1,638) Corporate debt securities 156,322 (476) 49,929 (881) 206,251 (1,357) Total $ 467,514 $ (1,065) $ 103,760 $ (2,462) $ 571,274 $ (3,527) Short-term investments that were in an unrealized loss position as of July 31, 2023 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 173,576 $ (1,875) $ — $ — $ 173,576 $ (1,875) U.S. government agency securities 119,558 (292) 131,530 (4,007) 251,088 (4,299) Corporate debt securities 232,504 (2,034) 82,599 (2,177) 315,103 (4,211) Total $ 525,638 $ (4,201) $ 214,129 $ (6,184) $ 739,767 $ (10,385) We review the individual securities that have unrealized losses in our short-term investment portfolio on a regular basis. We evaluate, among others, whether we have the intention to sell any of these investments and whether it is not more likely than not that we will be required to sell any of them before recovery of the amortized cost basis. Neither of these criteria were met in any period presented. We additionally evaluate whether the decline in fair value of the corporate debt securities below their amortized cost basis is related to credit losses or other factors. Based on this evaluation, we determined that unrealized losses of the above securities were primarily attributable to changes in interest rates and non-credit related factors. Accordingly, we determined that an allowance for credit losses was unnecessary for our short-term investments as of January 31, 2024 and July 31, 2023. As of January 31, 2024 and July 31, 2023, we recorded $10.0 million and $7.2 million, respectively, of accrued interest receivable within prepaid expenses and other current assets in the condensed consolidated balance sheets. Strategic Investments

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jan. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements We measure our financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Our money market funds are classified within Level I due to the highly liquid nature of these assets and have quoted prices in active markets. Certain of our investments in available-for-sale securities (i.e., U.S. treasury securities, U.S. government agency securities and corporate debt securities), as well as our assets and liabilities arising from our foreign currency forward contracts and our interest rate swap contracts, are classified within Level II. The fair value of our Level II financial assets and liabilities is determined by using inputs based on non-binding market consensus prices that are primarily corroborated by observable market data or quoted market prices for similar instruments, for substantially the full term of the financial assets and liabilities. Assets and liabilities that are measured at fair value on a recurring basis consisted of the following as of January 31, 2024: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 884,888 $ 884,888 $ — $ — U.S. treasury securities 148,822 — 148,822 — U.S. government agency securities 218,945 — 218,945 — Corporate debt securities 16,497 — 16,497 — Total cash equivalents $ 1,269,152 $ 884,888 $ 384,264 $ — Short-term investments: U.S. treasury securities $ 311,341 $ — $ 311,341 $ — U.S. government agency securities 148,908 — 148,908 — Corporate debt securities 560,969 — 560,969 — Total short-term investments $ 1,021,218 $ — $ 1,021,218 $ — Total cash equivalents and short-term investments $ 2,290,370 $ 884,888 $ 1,405,482 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 5,627 $ — $ 5,627 $ — Foreign currency contracts assets-noncurrent (2) $ 763 $ — $ 763 $ — Foreign currency contracts liabilities-current (3) $ 3,631 $ — $ 3,631 $ — Foreign currency contracts liabilities-noncurrent (4) $ 918 $ — $ 918 $ — Interest rate contracts assets-noncurrent (2) $ 607 $ — $ 607 $ — Interest rate contracts liabilities-current (3) $ 3,945 $ — $ 3,945 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 1,269 $ — $ 1,269 $ — Foreign currency contracts liabilities-current (3) $ 2,185 $ — $ 2,185 $ — (1) Included within prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Included within other noncurrent assets in the condensed consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Included within other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2023: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 768,003 $ 768,003 $ — $ — U.S. treasury securities 157,220 — 157,220 — U.S. government agency securities 166,636 — 166,636 — Corporate debt securities 38,800 — 38,800 — Total cash equivalents $ 1,130,659 $ 768,003 $ 362,656 $ — Short-term investments: U.S. treasury securities $ 173,576 $ — $ 173,576 $ — U.S. government agency securities 262,095 — 262,095 — Corporate debt securities 402,355 — 402,355 — Total short-term investments $ 838,026 $ — $ 838,026 $ — Total cash equivalents and short-term investments $ 1,968,685 $ 768,003 $ 1,200,682 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 12,581 $ — $ 12,581 $ — Foreign currency contract assets-noncurrent (2) $ 2,264 $ — $ 2,264 $ — Foreign currency contracts liabilities-current (3) $ 1,452 $ — $ 1,452 $ — Foreign currency contracts liabilities-noncurrent (4) $ 669 $ — $ 669 $ — Interest rate contracts liabilities-current (3) $ 6,439 $ — $ 6,439 $ — Interest rate contracts liabilities-noncurrent (4) $ 1,588 $ — $ 1,588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,061 $ — $ 2,061 $ — Foreign currency contracts liabilities-current (3) $ 465 $ — $ 465 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets. We did not have transfers between levels of the fair value hierarchy of assets measured at fair value during the periods presented. Refer to Note 9, Convertible Senior Notes, for the carrying amount and estimated fair value of our convertible senior notes as of January 31, 2024 and July 31, 2023.

Property and Equipment and Purc

Property and Equipment and Purchased Intangible Assets	6 Months Ended
	Jan. 31, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment and Purchased Intangible Assets	Property and Equipment and Purchased Intangible Assets Property and equipment consisted of the following: January 31, 2024 July 31, 2023 (in thousands) Hosting equipment $ 336,678 $ 280,851 Capitalized internal-use software 149,805 120,877 Computers and equipment 6,060 7,107 Purchased software 1,102 1,311 Furniture and fixtures 933 1,025 Leasehold improvements 8,278 7,608 Total property and equipment, gross 502,856 418,779 Less: Accumulated depreciation and amortization (208,361) (176,424) Total property and equipment, net $ 294,495 $ 242,355 Purchased intangible assets consist of internet protocol (IP) addresses and source codes, which are amortized on a straight-line basis over an estimated useful life ranging from five years to 10 years. As of January 31, 2024, their historical cost and accumulated amortization were $12.4 million and $2.2 million, respectively. As of July 31, 2023, their historical cost and accumulated amortization were $8.6 million and $1.6 million, respectively. Purchased intangible assets are included within other noncurrent assets in the condensed consolidated balance sheets. We recognized depreciation and amortization expense on property and equipment and purchased intangible assets of $15.4 million and $13.4 million for the three months ended January 31, 2024 and 2023, respectively, and $29.4 million and $25.2 million for the six months ended January 31, 2024 and 2023, respectively. Additionally, we recognized stock-based compensation expense on the amortization of capitalized stock-based compensation associated with capitalized internal-use software of $3.1 million and $2.0 million for the three months ended January 31, 2024 and 2023, respectively, and $5.9 million and $3.7 million for the six months ended January 31, 2024 and 2023, respectively.
Property and Equipment and Purchased Intangible Assets	Property and Equipment and Purchased Intangible Assets Property and equipment consisted of the following: January 31, 2024 July 31, 2023 (in thousands) Hosting equipment $ 336,678 $ 280,851 Capitalized internal-use software 149,805 120,877 Computers and equipment 6,060 7,107 Purchased software 1,102 1,311 Furniture and fixtures 933 1,025 Leasehold improvements 8,278 7,608 Total property and equipment, gross 502,856 418,779 Less: Accumulated depreciation and amortization (208,361) (176,424) Total property and equipment, net $ 294,495 $ 242,355 Purchased intangible assets consist of internet protocol (IP) addresses and source codes, which are amortized on a straight-line basis over an estimated useful life ranging from five years to 10 years. As of January 31, 2024, their historical cost and accumulated amortization were $12.4 million and $2.2 million, respectively. As of July 31, 2023, their historical cost and accumulated amortization were $8.6 million and $1.6 million, respectively. Purchased intangible assets are included within other noncurrent assets in the condensed consolidated balance sheets. We recognized depreciation and amortization expense on property and equipment and purchased intangible assets of $15.4 million and $13.4 million for the three months ended January 31, 2024 and 2023, respectively, and $29.4 million and $25.2 million for the six months ended January 31, 2024 and 2023, respectively. Additionally, we recognized stock-based compensation expense on the amortization of capitalized stock-based compensation associated with capitalized internal-use software of $3.1 million and $2.0 million for the three months ended January 31, 2024 and 2023, respectively, and $5.9 million and $3.7 million for the six months ended January 31, 2024 and 2023, respectively.

Business Combinations

Business Combinations	6 Months Ended
	Jan. 31, 2024
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations Securelyshare Software Private Ltd. On August 31, 2023, we completed the acquisition of Securelyshare Software Private Ltd. ("Securelyshare"), an early-stage technology company incorporated in India. We plan to integrate this company's technology into our cloud platform. Pursuant to the terms of the purchase agreement, the purchase price consideration was $5.3 million in cash, of which $0.8 million was held back as an indemnity holdback amount for eighteen months after the transaction closing date. The transaction was accounted for as a business combination. We recognized intangible assets of $2.8 million for developed technology and goodwill of $3.2 million. The developed technology is amortized over its economic useful life of five years. Goodwill represents the excess of the purchase price paid over the fair value of the net assets acquired and is primarily attributable to the acquired workforce and expected operating synergies and is not deductible for Indian income tax purposes. The acquisition qualified as a stock transaction for tax purposes. As a result, we recognized a deferred tax liability of $0.7 million, generated primarily from the difference between the tax basis and fair value of the acquired developed technology, which increased goodwill by the same amount.

Goodwill and Acquired Intangibl

Goodwill and Acquired Intangible Assets	6 Months Ended
	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Acquired Intangible Assets	Goodwill and Acquired Intangible Assets Goodwill The carrying amount of goodwill was $92.4 million and $89.2 million as of January 31, 2024 and July 31, 2023, respectively. Acquired Intangible Assets Acquired intangible assets consist of developed technology and customer relationships acquired through our business acquisitions and asset acquisitions. Acquired intangible assets are amortized using the straight-line method over their estimated useful lives. During the three and six months ended January 31, 2024, in connection with the acquisition of Securelyshare, we acquired developed technology with a fair value of $2.8 million with an estimated useful life of five years. For further information refer to Note 6, Business Combinations. Changes in acquired intangible assets for the six months ended January 31, 2024 consisted of the following: Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful life July 31, 2023 Additions January 31, 2024 July 31, 2023 Amortization Expense January 31, 2024 July 31, 2023 January 31, 2024 January 31, 2024 (in thousands) (years) Developed technology $ 53,456 $ 2,800 $ 56,256 $ (29,259) $ (5,667) $ (34,926) $ 24,197 $ 21,330 3.0 Customer relationships 3,560 — 3,560 (1,898) (452) (2,350) 1,662 1,210 2.0 Total $ 57,016 $ 2,800 $ 59,816 $ (31,157) $ (6,119) $ (37,276) $ 25,859 $ 22,540 2.9 Amortization expense of acquired intangible assets for the three and six months ended January 31, 2024 was $3.1 million and $6.1 million, respectively, and for the three and six months ended January 31, 2023 was $2.6 million and $5.1 million, respectively. Amortization expense of developed technology and customer relationships is included primarily within cost of revenue and sales and marketing expenses, respectively, in the condensed consolidated statements of operations. Future amortization expense of acquired intangible assets as of January 31, 2024 consists of the following: Amount Fiscal Year ending July 31, (in thousands) 2024 (remaining six months) $ 5,714 2025 6,825 2026 5,812 2027 2,988 2028 1,155 2029 46 Total $ 22,540

Derivative Instruments

Derivative Instruments	6 Months Ended
	Jan. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments Foreign Currency Forward Contracts As a global business, we are exposed to foreign currency exchange rate risk. Substantially all of our revenue is transacted in U.S. dollars; however, a portion of our cost of revenue and operating expenditures are incurred outside of the United States and are denominated in foreign currencies, making them subject to fluctuations in foreign currency exchange rates. In order to mitigate the impact of foreign currency fluctuations on our future cash flows and earnings, we enter into foreign currency forward contracts, which we designate as cash flow hedges. All cash flow hedges were considered effective during the three and six months ended January 31, 2024 and 2023. We also use foreign currency forward contracts to mitigate variability in gains and losses generated from the remeasurement of certain monetary assets and liabilities denominated in foreign currencies. The outstanding non-designated derivative instruments are carried at fair value with the change in fair value recorded in other income (expense), net in the condensed consolidated statement of operations in the same period as the changes in fair value from the remeasurement of the underlying assets and liabilities. Cash flows from such derivatives are classified as operating activities. These foreign exchange contracts typically have maturities of approximately one As of January 31, 2024 and July 31, 2023, the total notional amount of our outstanding designated foreign currency forward contracts was $487.6 million and $457.6 million, respectively, and for our outstanding non-designated foreign currency forward contracts was $230.6 million and $182.9 million, respectively. The maximum length of time over which forecasted foreign currency denominated operating expenses are hedged is 21 months. As of January 31, 2024, an estimated $1.2 million of the unrealized loss related to our cash flow hedges are expected to be released into earnings over the next 12 months. Refer to Note 4, Fair Value Measurements, for the fair value of our derivative instruments as reported on the condensed consolidated balance sheet as of January 31, 2024 and July 31, 2023. During the three and six months ended January 31, 2024 and 2023, changes in the fair value of our non-designated derivative instruments recorded within other income (expense), net within the condensed consolidated statement of operations, were not material. The changes in accumulated other comprehensive income (loss) ("AOCI") related to our cash flow hedges consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 (in thousands) Balance of AOCI as of the beginning of the period $ (6,853) $ (23,070) $ 8,937 $ (13,744) Net unrealized gains (losses) recognized in accumulated other comprehensive income 7,353 24,019 (7,783) 9,980 (Gains) losses reclassified from AOCI into the condensed consolidated statement of operations (1) (1,611) 4,267 (2,265) 8,980 Balance of AOCI as of the end of the period $ (1,111) $ 5,216 $ (1,111) $ 5,216 (1) (Gains) losses related to our cash flow hedges reclassified from AOCI into the condensed consolidated statement of operations consisted of the following : Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 (in thousands) Cost of revenue $ (321) $ 706 $ (497) $ 1,413 Sales and marketing (1,029) 2,757 (1,324) 6,053 Research and development (123) 583 (215) 1,047 General and administrative (138) 221 (229) 467 Total $ (1,611) $ 4,267 $ (2,265) $ 8,980 Our derivative contracts expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the underlying contracts. We mitigate this credit risk by transacting with major financial institutions with high credit ratings and standards. We periodically assess the creditworthiness of our counterparties to ensure they continue to meet our credit quality requirements. We also enter into master netting arrangements, which permit net settlement of transactions with the same counterparty. The potential impact of these rights of set-off associated with our derivative instruments was not material as of January 31, 2024 and July 31, 2023. We are not required to pledge, and are not entitled to receive, cash collateral related to these derivative instruments. We do not enter into derivative contracts for trading or speculative purposes. Interest Rate Swap Contracts During the three months ended April 30, 2023, we entered into interest rate swaps contracts, maturing on July 1, 2025, designated as fair value hedges intended to hedge a portion of our fair value risk exposure due to changing interest rates by economically converting the fixed interest rate of a certain tranche of our convertible senior notes to a floating interest rate. As of January 31, 2024, the carrying amount of the hedged convertible senior notes was $498.5 million and the total notional amount of our outstanding interest rate swaps was $500.0 million. The gains and losses related to changes in the fair value of the interest rate swaps are included within interest expense in the condensed consolidated statement of operations and substantially offset changes in the fair value of the hedged portion of the underlying convertible senior notes that are attributable to the changes in underlying benchmark interest rates. As of January 31, 2024 and July 31, 2023, the cumulative amount of fair value hedge accounting adjustments included in the carrying amount of hedged liabilities was $3.4 million and $8.3 million, respectively. The effect of derivative instruments designated as fair value hedges included within interest expense in the condensed statement of operations consisted of the following: Gains (Losses) Three Months Ended January 31, 2024 Six Months Ended January 31, 2024 (in thousands) Interest rate swaps: Hedged items $ 6,007 $ 4,897 Derivatives designated as hedging instruments (5,783) (4,689) Total $ 224 $ 208

Convertible Senior Notes

Convertible Senior Notes	6 Months Ended
	Jan. 31, 2024
Debt Disclosure [Abstract]
Convertible Senior Notes	Convertible Senior Notes On June 25, 2020, we issued $1,150.0 million in aggregate principal amount of 0.125% convertible senior notes due 2025 (the “Notes”), including the exercise in full by the initial purchasers of the Notes of their option to purchase an additional $150.0 million principal amount of the Notes. The Notes are unsecured obligations and bear interest at a rate of 0.125% per year and interest is payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2021. The Notes mature on July 1, 2025, unless earlier converted, redeemed or repurchased. The total net proceeds from the offering, after deducting initial purchase discounts and other debt issuance costs, was $1,130.5 million. Refer to Note 10, Convertible Senior Notes, to the audited consolidated financial statements included in our Fiscal 2023 Form 10-K for further information on the Notes. During the three months ended January 31, 2024, the conditional conversion feature of the Notes was triggered as the last reported sale price of our common stock was greater than or equal to 130% of the conversion price of the Notes for at least 20 trading days during the period of 30 consecutive trading days ending on January 31, 2024. Accordingly, the Notes are currently convertible, in whole or in part, at the option of the holders from February 1, 2024 through April 30, 2024 (the last trading day of the fiscal quarter). Whether the Notes will be convertible following such period will depend on the continued satisfaction of this condition or another conversion condition in the future. During the three months ended April 30, 2023, we entered into interest rate swap contracts designated as fair value hedges of certain of our Notes. For further information refer to Note 8, Derivative Instruments. The net carrying amount of the liability component of the Notes consisted of the following: January 31, July 31, 2024 2023 (in thousands) Principal amount $ 1,149,993 $ 1,149,993 Less: Unamortized debt issuance costs 5,573 7,528 Hedge accounting fair value adjustments 3,409 8,306 Total $ 1,141,011 $ 1,134,159 The interest expense related to the Notes consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 (in thousands) Contractual interest expense $ 359 $ 360 $ 718 $ 719 Amortization of debt issuance costs 978 973 1,955 1,945 Total $ 1,337 $ 1,333 $ 2,673 $ 2,664 The total fair value of the Notes was $1,843.3 million and $1,411.4 million as of January 31, 2024 and July 31, 2023, respectively. The fair value was determined based on the closing trading price per $1,000 of the Notes as of the last day of trading for the period. We consider the fair value of the Notes as of January 31, 2024 to be a Level II measurement as they are not actively traded. The fair value of the Notes is primarily affected by the trading price of our common stock and market interest rates. In connection with the pricing of the Notes, we entered into capped call transactions with the option counterparties (the "Capped Calls"). The Capped Calls each have an initial strike price of $150.80 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have an initial cap price of $246.76 per share, subject to certain adjustments. The Capped Calls are generally expected to reduce potential dilution to our common stock upon any conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of the converted Notes, as the case may be, with such reduction and/or offset subject to a cap. During the three and six months ended January 31, 2024 and 2023 , we have not exercised any Capped Call options. Refer to Note 10, Convertible Senior Notes, to the audited consolidated financial statements included in our Fiscal 2023 Form 10-K for further information on the Capped Calls.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jan. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Non-cancelable Purchase Obligations In the normal course of business, we enter into non-cancelable purchase commitments with various third parties to purchase products and services such as technology equipment, subscription-based cloud service arrangements, corporate and marketing events and consulting services. As of January 31, 2024, there have been no material changes outside the ordinary course of our business to our non-cancelable purchase obligations from those disclosed in the Fiscal 2023 Form 10-K, except for a Cloud Platform Service agreement entered with a third-party service provider in December 2023 for a total minimum purchase commitment of $100.0 million over a five-year term. Legal Matters We are a party to various litigation matters from time to time and subject to claims that arise in the ordinary course of business, including patent, commercial, product liability, employment, class action, whistleblower and other litigation and claims, as well as governmental and other regulatory investigations and proceedings. In addition, third parties may from time to time assert claims against us in the form of letters and other communications. There is no pending or threatened legal proceeding to which we are a party that, in our opinion, is likely to have a material adverse effect on our future financial results or operations; however, the results of litigation and claims are inherently unpredictable. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. The expense of litigation and the timing of this expense from period to period are difficult to estimate, subject to change and could adversely affect our results of operations.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jan. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Equity Incentive Plan Equity incentive awards which may be granted to eligible participants under our Fiscal Year 2018 Equity Incentive Plan (the "Plan") include restricted stock units, restricted stock, stock options, nonstatutory stock options, stock appreciation rights, performance units and performance shares. Stock Options The activity of stock options for the six months ended January 31, 2024 consisted of the following: Outstanding Weighted-Average Weighted-Average Aggregate (in thousands, except per share amounts) Balance as of July 31, 2023 1,267 $18.54 2.1 $ 179,678 Granted 50 $198.03 — — Exercised (468) $8.23 — $ 87,640 Canceled, forfeited or expired — — — — Balance as of January 31, 2024 849 $34.80 1.8 $ 170,500 Exercisable and expected to vest as of July 31, 2023 1,210 $12.82 1.8 $ 178,616 Exercisable and expected to vest as of January 31, 2024 749 $16.00 0.8 $ 164,484 The aggregate intrinsic value of the options exercised represents the difference between the fair value of our common stock on the date of exercise and their exercise price. The total intrinsic value of options exercised for the six months ended January 31, 2024 and 2023 was $87.6 million and $30.0 million, respectively. The weighted-average grant-date fair value per share of stock options granted in the six months ended January 31, 2024 was $198.03. We estimate the fair value of stock options using the Black-Scholes option pricing model with the following assumptions: Six Months Ended January 31, 2024 Expected term (in years) 6.0 Expected stock price volatility 59.5% Risk-free interest rate 4.2% Dividend yield 0.0% There were no stock options granted during the six months ended January 31, 2023. Restricted Stock Units and Performance Stock Awards The activity of restricted stock units ("RSUs") and performance stock awards ("PSAs") consisted of the following for the six months ended January 31, 2024: Underlying Shares Weighted-Average Grant Date Fair Value Aggregate (in thousands, except per share data) Balance as of July 31, 2023 9,351 $139.95 $ 1,499,714 Granted 3,501 $173.32 Vested (1,945) $133.52 $ 366,164 Canceled or forfeited (654) $156.13 Balance as of January 31, 2024 10,253 $151.53 $ 2,416,430 As of January 31, 2024, the number of outstanding PSAs for which the performance metrics have not been defined as of such date was not material. These awards are not considered granted for accounting purposes as of January 31, 2024 and accordingly, have been excluded from the above table. Employee Stock Purchase Plan In fiscal 2018, we adopted the Fiscal Year 2018 Employee Stock Purchase Plan (the "ESPP"). During the three months ended January 31, 2024, employees purchased 0.2 million shares of our common stock under the ESPP at an average purchase price of $104.69 per share, resulting in total cash proceeds of $18.4 million. ESPP employee payroll contributions accrued as of January 31, 2024 and July 31, 2023, were $9.7 million and $7.4 million, respectively, and are included within accrued compensation in the condensed consolidated balance sheets. Payroll contributions accrued as of January 31, 2024 will be used to purchase shares at the end of the current ESPP purchase period ending on June 15, 2024. Payroll contributions ultimately used to purchase shares are reclassified to stockholders’ equity on the purchase date. The fair value of the purchase right for the ESPP was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Six Months Ended January 31, 2024 2023 Expected term (in years) 0.5 - 2.0 0.5 - 2.0 Expected stock price volatility 42.5% - 64.8% 62.4% - 75.9% Risk-free interest rate 4.4% - 5.3% 4.2% - 4.7% Dividend yield 0.0% 0.0% Departure of the President of the Company In October 2022, our President, who led research and development activities, resigned from his position as President of the Company but continued to serve as a member of our Board of Directors through January 2024. In connection with his resignation as President of the Company, we recognized a reversal of stock-based compensation expense of $9.9 million associated with the cancellation of unvested incentive equity awards which was recognized in research and development expenses in the condensed consolidated statement of operations for the six months ended January 31, 2023. Stock-based Compensation Expense The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 (in thousands) Cost of revenue $ 13,029 $ 9,410 $ 25,613 $ 17,842 Sales and marketing 63,044 54,213 119,674 107,848 Research and development 42,872 29,005 83,065 53,536 General and administrative 21,487 17,110 41,218 35,685 Total $ 140,432 $ 109,738 $ 269,570 $ 214,911 During the three months ended January 31, 2024 and 2023, we capitalized stock-based compensation associated with the development of software for internal-use of $6.4 million and $4.3 million, respectively. During the six months ended January 31, 2024 and 2023, the amount capitalized was $11.2 million and $8.3 million, respectively.

Income Taxes

Income Taxes	6 Months Ended
	Jan. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our tax provision for interim periods is determined using an estimate of our annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, we update our estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, we make a cumulative adjustment in such period. Our quarterly tax provision, and estimate of our annual effective tax rate, is subject to variation due to several factors, including variability in pre-tax income (or loss), the mix of jurisdictions to which such income relates, changes in how we do business, and tax law developments. Our estimated annual effective tax rate for the year differs from the U.S. statutory rate of 21% as a result of our U.S. losses for which no benefit will be realized, as well as our foreign operations which are subject to tax rates that differ from those in the United States. We recorded provision for income taxes of $8.0 million a nd $3.7 million for the three months ended January 31, 2024 and 2023, respectively, and $17.0 million and $8.4 million for the six months ended January 31, 2024 and 2023. The increase for the three months ended January 31, 2024 is primarily driven by the increase in foreign tax related to the increase in our pre-tax income in the foreign jurisdictions in which we conduct business. The increase for the six months ended January 31, 2024 is primarily driven by the increase in foreign tax related to the increase in our pre-tax income in the foreign jurisdictions in which we conduct business and the integration of business acquisitions. We are subject to income tax in the United States as well as other tax jurisdictions in which we conduct business. Earnings from our non-U.S. operations are subject to income taxes in the countries in which we operate. The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. We assess our ability to realize the deferred tax assets on a quarterly basis and we establish a valuation allowance if it is more-likely-than-not that some portion of the deferred tax assets will not be realized. We weigh all available positive and negative evidence, including our earnings history and results of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income and tax planning strategies. Due to the weight of objectively verifiable negative evidence, including our history of losses in certain jurisdictions, we believe that it is more likely than not that our U.S. federal, state, and the United Kingdom ("U.K.") deferred tax assets will not be realized. Accordingly, we have maintained a valuation allowance on our U.S. federal, state and U.K. deferred tax assets.

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jan. 31, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The computation of basic and diluted net loss per share consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 (in thousands) Net loss $ (28,469) $ (57,453) $ (61,952) $ (125,615) Weighted-average shares used in computing net loss per share, basic and diluted 148,951 144,511 148,287 144,001 Net loss per share, basic and diluted $ (0.19) $ (0.40) $ (0.42) $ (0.87) Since we have reported net losses for all periods presented, we have excluded all potentially dilutive securities from the calculation of the diluted net loss per share as their effect is antidilutive and accordingly, the basic and diluted net loss per share is the same for all periods presented. We calculated the potential dilutive effect of the Notes under the if-converted method. Under this method, diluted earnings per share are determined by assuming that all of the Notes were converted into shares of our common stock at the beginning of the reporting period. In connection with the issuance of the Notes, we entered into Capped Calls, which were not included for purposes of calculating the number of diluted shares outstanding, as their effect would have been anti-dilutive. The Capped Calls are expected to partially offset the potential dilution to our common stock upon any conversion of the Notes. We have not exercised any of the Capped Calls as of January 31, 2024. The outstanding potentially dilutive securities that were excluded from the computation of diluted net loss per share as their effect would be antidilutive consisted of the following: January 31, 2024 2023 (in thousands) Unvested RSUs and shares of common stock 9,275 6,747 Stock options 849 1,444 Unvested PSAs (1) 1,056 721 Share purchase rights under the ESPP 826 796 Notes (2) 7,626 7,626 Total 19,632 17,334 (1) The number of unvested PSAs is estimated at 100% of the target number of shares granted and excludes unvested PSAs for which performance conditions have not been established as of January 31, 2024 and 2023, as they are not considered outstanding for accounting purposes. For further information refer to Note 11, Stock-Based Compensation. (2) The shares underlying the conversion option in the Notes were not considered in the calculation of diluted net loss per share as the effect would have been antidilutive. Based on the initial conversion price, the entire outstanding principal amount of the Notes as of January 31, 2024 would have been convertible into approximately 7.6 million shares of our common stock, which is reflected in the above table. Conversion notices received through January 31, 2024, have not been material. In connection with the issuance of the Notes, we entered into Capped Calls, which have not been included in the computation of the number of diluted shares outstanding, as their effect would be antidilutive. The Capped Calls are expected to partially offset the potential dilution to our common stock upon any conversion of the Notes.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss) Attributable to Parent	$ (28,469)	$ (57,453)	$ (61,952)	$ (125,615)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	6 Months Ended
	Jan. 31, 2024 shares	Jan. 31, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		Securities Trading Plans of Directors and Executive Officers During three months ended January 31, 2024, the following officer, as defined in Rule 16a-1(f) under the Securities Act of 1934, as amended, adopted a “Rule 10b5-1 trading arrangement” as defined in Regulation S-K Item 408, as follows:
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Remo Canessa [Member]
Trading Arrangements, by Individual
Name	Remo Canessa
Title	chief financial officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	January 4, 2024
Arrangement Duration	456 days
Aggregate Available	50,000	50,000

Business and Summary of Signi_2

Business and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") and applicable regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the applicable required disclosures and regulations of the SEC. Therefore, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's audited consolidated financial statements and related notes in its Annual Report on Form 10-K for the fiscal year ended July 31, 2023 (the "Fiscal 2023 Form 10-K"), as filed with the SEC on September 14, 2023.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal-use software, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the condensed consolidated financial statements. Due to uncertainty in the macroeconomic environment, including but not limited to the effects of inflation, and geopolitical events, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained . In August 2023, we completed an assessment of the useful lives of our servers and networking equipment, which resulted in an extension of their useful lives from four
Fiscal Year	Fiscal Year Our fiscal year ends on July 31. References to fiscal 2024, for example, refer to our fiscal year ending July 31, 2024.
Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU No. 2023-07, Segment Reporting (Topic 280 ): Improvements to Reportable Segment Disclosures , which requires disclosure of incremental segment information on an annual and interim basis. Th is standard is effective for us in the first quarter of fiscal 2025. We are currently evaluating the potential impact of this standard. In December 2023, the FASB issued 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amended guidance enhances income tax disclosures primarily related to the effective tax rate reconciliation and income taxes paid information. This guidance requires disclosures of specific categories in the effective tax rate reconciliation and further information on reconciling items meeting a quantitative threshold. In addition, the amended guidance requires disaggregating income taxes paid (net of refunds received) by federal, state and foreign taxes. It also requires disaggregating individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 % of total income taxes paid (net of refunds received). Th

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Jan. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use our cloud platform: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 Amount % Revenue Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except for percentage data) United States $ 263,970 50 % $ 193,508 50 % $ 511,502 50 % $ 369,023 50 % Europe, Middle East and Africa 164,009 31 % 124,742 32 % 321,254 31 % 241,749 32 % Asia Pacific 79,077 15 % 57,602 15 % 154,157 15 % 109,858 15 % Other 17,943 4 % 11,746 3 % 34,789 4 % 22,516 3 % Total $ 524,999 100 % $ 387,598 100 % $ 1,021,702 100 % $ 743,146 100 % The following table summarizes the revenue from contracts by type of customer: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 Amount % Revenue Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except for percentage data) Channel partners $ 480,592 92 % $ 358,165 92 % $ 935,047 92 % $ 687,522 93 % Direct customers 44,407 8 % 29,433 8 % 86,655 8 % 55,624 7 % Total $ 524,999 100 % $ 387,598 100 % $ 1,021,702 100 % $ 743,146 100 %
Schedule of Capitalized Contract Cost	The activity of the deferred contract acquisition costs consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 (in thousands) Beginning balance $ 372,803 $ 301,472 $ 375,234 $ 297,002 Capitalization of contract acquisition costs 40,064 37,407 67,744 64,202 Amortization of deferred contract acquisition costs (31,393) (23,728) (61,504) (46,053) Ending balance $ 381,474 $ 315,151 $ 381,474 $ 315,151 The outstanding balance of the deferred contract acquisition costs consisted of the following: January 31, 2024 July 31, 2023 (in thousands) Deferred contract acquisition costs, current $ 125,591 $ 115,827 Deferred contract acquisition costs, noncurrent 255,883 259,407 Total deferred contract acquisition costs $ 381,474 $ 375,234

Cash Equivalents and Short-Te_2

Cash Equivalents and Short-Term Investments (Tables)	6 Months Ended
	Jan. 31, 2024
Cash and Cash Equivalents [Abstract]
Schedule of Cash Equivalents and Short-Term Investments	Cash equivalents and short-term investments consisted of the following as of January 31, 2024: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 884,888 $ — $ — $ 884,888 U.S. treasury securities 148,846 — (24) 148,822 U.S. government agency securities 218,975 — (30) 218,945 Corporate debt securities 16,497 — — 16,497 Total cash equivalents $ 1,269,206 $ — $ (54) $ 1,269,152 Short-term investments: U.S. treasury securities $ 311,785 $ 88 $ (532) $ 311,341 U.S. government agency securities 150,437 109 (1,638) 148,908 Corporate debt securities 560,726 1,600 (1,357) 560,969 Total short-term investments $ 1,022,948 $ 1,797 $ (3,527) $ 1,021,218 Total cash equivalents and short-term investments $ 2,292,154 $ 1,797 $ (3,581) $ 2,290,370 Cash equivalents and short-term investments consisted of the following as of July 31, 2023: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 768,003 $ — $ — $ 768,003 U.S. treasury securities 157,250 — (30) 157,220 U.S. government agency securities 166,671 — (35) 166,636 Corporate debt securities 38,800 — — 38,800 Total cash equivalents $ 1,130,724 $ — $ (65) $ 1,130,659 Short-term investments: U.S. treasury securities $ 175,451 $ — $ (1,875) $ 173,576 U.S. government agency securities 266,392 2 (4,299) 262,095 Corporate debt securities 406,517 49 (4,211) 402,355 Total short-term investments $ 848,360 $ 51 $ (10,385) $ 838,026 Total cash equivalents and short-term investments $ 1,979,084 $ 51 $ (10,450) $ 1,968,685
Schedule of Maturities	The amortized cost and fair value of our short-term investments based on their stated maturities consisted of the following as of January 31, 2024: Amortized Fair Value (in thousands) Due within one year $ 575,536 $ 572,868 Due between one to three years 447,412 448,350 Total $ 1,022,948 $ 1,021,218
Schedule of Unrealized Loss on Investments	Short-term investments that were in an unrealized loss position as of January 31, 2024 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 242,238 $ (532) $ — $ — $ 242,238 $ (532) U.S. government agency securities 68,954 (57) 53,831 (1,581) 122,785 (1,638) Corporate debt securities 156,322 (476) 49,929 (881) 206,251 (1,357) Total $ 467,514 $ (1,065) $ 103,760 $ (2,462) $ 571,274 $ (3,527) Short-term investments that were in an unrealized loss position as of July 31, 2023 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 173,576 $ (1,875) $ — $ — $ 173,576 $ (1,875) U.S. government agency securities 119,558 (292) 131,530 (4,007) 251,088 (4,299) Corporate debt securities 232,504 (2,034) 82,599 (2,177) 315,103 (4,211) Total $ 525,638 $ (4,201) $ 214,129 $ (6,184) $ 739,767 $ (10,385)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jan. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets Measured on Recurring Basis	Assets and liabilities that are measured at fair value on a recurring basis consisted of the following as of January 31, 2024: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 884,888 $ 884,888 $ — $ — U.S. treasury securities 148,822 — 148,822 — U.S. government agency securities 218,945 — 218,945 — Corporate debt securities 16,497 — 16,497 — Total cash equivalents $ 1,269,152 $ 884,888 $ 384,264 $ — Short-term investments: U.S. treasury securities $ 311,341 $ — $ 311,341 $ — U.S. government agency securities 148,908 — 148,908 — Corporate debt securities 560,969 — 560,969 — Total short-term investments $ 1,021,218 $ — $ 1,021,218 $ — Total cash equivalents and short-term investments $ 2,290,370 $ 884,888 $ 1,405,482 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 5,627 $ — $ 5,627 $ — Foreign currency contracts assets-noncurrent (2) $ 763 $ — $ 763 $ — Foreign currency contracts liabilities-current (3) $ 3,631 $ — $ 3,631 $ — Foreign currency contracts liabilities-noncurrent (4) $ 918 $ — $ 918 $ — Interest rate contracts assets-noncurrent (2) $ 607 $ — $ 607 $ — Interest rate contracts liabilities-current (3) $ 3,945 $ — $ 3,945 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 1,269 $ — $ 1,269 $ — Foreign currency contracts liabilities-current (3) $ 2,185 $ — $ 2,185 $ — (1) Included within prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Included within other noncurrent assets in the condensed consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Included within other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2023: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 768,003 $ 768,003 $ — $ — U.S. treasury securities 157,220 — 157,220 — U.S. government agency securities 166,636 — 166,636 — Corporate debt securities 38,800 — 38,800 — Total cash equivalents $ 1,130,659 $ 768,003 $ 362,656 $ — Short-term investments: U.S. treasury securities $ 173,576 $ — $ 173,576 $ — U.S. government agency securities 262,095 — 262,095 — Corporate debt securities 402,355 — 402,355 — Total short-term investments $ 838,026 $ — $ 838,026 $ — Total cash equivalents and short-term investments $ 1,968,685 $ 768,003 $ 1,200,682 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 12,581 $ — $ 12,581 $ — Foreign currency contract assets-noncurrent (2) $ 2,264 $ — $ 2,264 $ — Foreign currency contracts liabilities-current (3) $ 1,452 $ — $ 1,452 $ — Foreign currency contracts liabilities-noncurrent (4) $ 669 $ — $ 669 $ — Interest rate contracts liabilities-current (3) $ 6,439 $ — $ 6,439 $ — Interest rate contracts liabilities-noncurrent (4) $ 1,588 $ — $ 1,588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,061 $ — $ 2,061 $ — Foreign currency contracts liabilities-current (3) $ 465 $ — $ 465 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets.
Schedule of Fair Value, Liabilities Measured on Recurring Basis	Assets and liabilities that are measured at fair value on a recurring basis consisted of the following as of January 31, 2024: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 884,888 $ 884,888 $ — $ — U.S. treasury securities 148,822 — 148,822 — U.S. government agency securities 218,945 — 218,945 — Corporate debt securities 16,497 — 16,497 — Total cash equivalents $ 1,269,152 $ 884,888 $ 384,264 $ — Short-term investments: U.S. treasury securities $ 311,341 $ — $ 311,341 $ — U.S. government agency securities 148,908 — 148,908 — Corporate debt securities 560,969 — 560,969 — Total short-term investments $ 1,021,218 $ — $ 1,021,218 $ — Total cash equivalents and short-term investments $ 2,290,370 $ 884,888 $ 1,405,482 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 5,627 $ — $ 5,627 $ — Foreign currency contracts assets-noncurrent (2) $ 763 $ — $ 763 $ — Foreign currency contracts liabilities-current (3) $ 3,631 $ — $ 3,631 $ — Foreign currency contracts liabilities-noncurrent (4) $ 918 $ — $ 918 $ — Interest rate contracts assets-noncurrent (2) $ 607 $ — $ 607 $ — Interest rate contracts liabilities-current (3) $ 3,945 $ — $ 3,945 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 1,269 $ — $ 1,269 $ — Foreign currency contracts liabilities-current (3) $ 2,185 $ — $ 2,185 $ — (1) Included within prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Included within other noncurrent assets in the condensed consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Included within other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2023: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 768,003 $ 768,003 $ — $ — U.S. treasury securities 157,220 — 157,220 — U.S. government agency securities 166,636 — 166,636 — Corporate debt securities 38,800 — 38,800 — Total cash equivalents $ 1,130,659 $ 768,003 $ 362,656 $ — Short-term investments: U.S. treasury securities $ 173,576 $ — $ 173,576 $ — U.S. government agency securities 262,095 — 262,095 — Corporate debt securities 402,355 — 402,355 — Total short-term investments $ 838,026 $ — $ 838,026 $ — Total cash equivalents and short-term investments $ 1,968,685 $ 768,003 $ 1,200,682 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 12,581 $ — $ 12,581 $ — Foreign currency contract assets-noncurrent (2) $ 2,264 $ — $ 2,264 $ — Foreign currency contracts liabilities-current (3) $ 1,452 $ — $ 1,452 $ — Foreign currency contracts liabilities-noncurrent (4) $ 669 $ — $ 669 $ — Interest rate contracts liabilities-current (3) $ 6,439 $ — $ 6,439 $ — Interest rate contracts liabilities-noncurrent (4) $ 1,588 $ — $ 1,588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,061 $ — $ 2,061 $ — Foreign currency contracts liabilities-current (3) $ 465 $ — $ 465 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets.

Property and Equipment and Pu_2

Property and Equipment and Purchased Intangible Assets (Tables)	6 Months Ended
	Jan. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following: January 31, 2024 July 31, 2023 (in thousands) Hosting equipment $ 336,678 $ 280,851 Capitalized internal-use software 149,805 120,877 Computers and equipment 6,060 7,107 Purchased software 1,102 1,311 Furniture and fixtures 933 1,025 Leasehold improvements 8,278 7,608 Total property and equipment, gross 502,856 418,779 Less: Accumulated depreciation and amortization (208,361) (176,424) Total property and equipment, net $ 294,495 $ 242,355

Goodwill and Acquired Intangi_2

Goodwill and Acquired Intangible Assets (Tables)	6 Months Ended
	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquired Intangible Assets	Changes in acquired intangible assets for the six months ended January 31, 2024 consisted of the following: Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful life July 31, 2023 Additions January 31, 2024 July 31, 2023 Amortization Expense January 31, 2024 July 31, 2023 January 31, 2024 January 31, 2024 (in thousands) (years) Developed technology $ 53,456 $ 2,800 $ 56,256 $ (29,259) $ (5,667) $ (34,926) $ 24,197 $ 21,330 3.0 Customer relationships 3,560 — 3,560 (1,898) (452) (2,350) 1,662 1,210 2.0 Total $ 57,016 $ 2,800 $ 59,816 $ (31,157) $ (6,119) $ (37,276) $ 25,859 $ 22,540 2.9
Schedule of Future Amortization Expense	Future amortization expense of acquired intangible assets as of January 31, 2024 consists of the following: Amount Fiscal Year ending July 31, (in thousands) 2024 (remaining six months) $ 5,714 2025 6,825 2026 5,812 2027 2,988 2028 1,155 2029 46 Total $ 22,540

Derivative Instruments (Tables)

Derivative Instruments (Tables)	6 Months Ended
	Jan. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Changes of AOCI Related to our Cash Flow Hedges and Cash Flow Hedges on our Consolidated Statement of Operations	The changes in accumulated other comprehensive income (loss) ("AOCI") related to our cash flow hedges consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 (in thousands) Balance of AOCI as of the beginning of the period $ (6,853) $ (23,070) $ 8,937 $ (13,744) Net unrealized gains (losses) recognized in accumulated other comprehensive income 7,353 24,019 (7,783) 9,980 (Gains) losses reclassified from AOCI into the condensed consolidated statement of operations (1) (1,611) 4,267 (2,265) 8,980 Balance of AOCI as of the end of the period $ (1,111) $ 5,216 $ (1,111) $ 5,216 (1) (Gains) losses related to our cash flow hedges reclassified from AOCI into the condensed consolidated statement of operations consisted of the following : Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 (in thousands) Cost of revenue $ (321) $ 706 $ (497) $ 1,413 Sales and marketing (1,029) 2,757 (1,324) 6,053 Research and development (123) 583 (215) 1,047 General and administrative (138) 221 (229) 467 Total $ (1,611) $ 4,267 $ (2,265) $ 8,980
Schedule of Derivative Instruments Designated as Fair Value Hedges	The effect of derivative instruments designated as fair value hedges included within interest expense in the condensed statement of operations consisted of the following: Gains (Losses) Three Months Ended January 31, 2024 Six Months Ended January 31, 2024 (in thousands) Interest rate swaps: Hedged items $ 6,007 $ 4,897 Derivatives designated as hedging instruments (5,783) (4,689) Total $ 224 $ 208

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	6 Months Ended
	Jan. 31, 2024
Debt Disclosure [Abstract]
Schedule of Convertible Senior Notes	The net carrying amount of the liability component of the Notes consisted of the following: January 31, July 31, 2024 2023 (in thousands) Principal amount $ 1,149,993 $ 1,149,993 Less: Unamortized debt issuance costs 5,573 7,528 Hedge accounting fair value adjustments 3,409 8,306 Total $ 1,141,011 $ 1,134,159 The interest expense related to the Notes consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 (in thousands) Contractual interest expense $ 359 $ 360 $ 718 $ 719 Amortization of debt issuance costs 978 973 1,955 1,945 Total $ 1,337 $ 1,333 $ 2,673 $ 2,664

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jan. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Options	The activity of stock options for the six months ended January 31, 2024 consisted of the following: Outstanding Weighted-Average Weighted-Average Aggregate (in thousands, except per share amounts) Balance as of July 31, 2023 1,267 $18.54 2.1 $ 179,678 Granted 50 $198.03 — — Exercised (468) $8.23 — $ 87,640 Canceled, forfeited or expired — — — — Balance as of January 31, 2024 849 $34.80 1.8 $ 170,500 Exercisable and expected to vest as of July 31, 2023 1,210 $12.82 1.8 $ 178,616 Exercisable and expected to vest as of January 31, 2024 749 $16.00 0.8 $ 164,484
Schedule of Valuation Assumptions	We estimate the fair value of stock options using the Black-Scholes option pricing model with the following assumptions: Six Months Ended January 31, 2024 Expected term (in years) 6.0 Expected stock price volatility 59.5% Risk-free interest rate 4.2% Dividend yield 0.0%
Schedule of Restricted Stock Units and Performance Stock Awards Activity	The activity of restricted stock units ("RSUs") and performance stock awards ("PSAs") consisted of the following for the six months ended January 31, 2024: Underlying Shares Weighted-Average Grant Date Fair Value Aggregate (in thousands, except per share data) Balance as of July 31, 2023 9,351 $139.95 $ 1,499,714 Granted 3,501 $173.32 Vested (1,945) $133.52 $ 366,164 Canceled or forfeited (654) $156.13 Balance as of January 31, 2024 10,253 $151.53 $ 2,416,430
Schedule of ESPP Valuation Assumptions	The fair value of the purchase right for the ESPP was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Six Months Ended January 31, 2024 2023 Expected term (in years) 0.5 - 2.0 0.5 - 2.0 Expected stock price volatility 42.5% - 64.8% 62.4% - 75.9% Risk-free interest rate 4.4% - 5.3% 4.2% - 4.7% Dividend yield 0.0% 0.0%
Schedule of Allocation of Stock-based Compensation Expense	The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 (in thousands) Cost of revenue $ 13,029 $ 9,410 $ 25,613 $ 17,842 Sales and marketing 63,044 54,213 119,674 107,848 Research and development 42,872 29,005 83,065 53,536 General and administrative 21,487 17,110 41,218 35,685 Total $ 140,432 $ 109,738 $ 269,570 $ 214,911

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Jan. 31, 2024
Earnings Per Share [Abstract]
Schedule of Net Loss Per Share, Basic and Diluted	The computation of basic and diluted net loss per share consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 (in thousands) Net loss $ (28,469) $ (57,453) $ (61,952) $ (125,615) Weighted-average shares used in computing net loss per share, basic and diluted 148,951 144,511 148,287 144,001 Net loss per share, basic and diluted $ (0.19) $ (0.40) $ (0.42) $ (0.87)
Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share	The outstanding potentially dilutive securities that were excluded from the computation of diluted net loss per share as their effect would be antidilutive consisted of the following: January 31, 2024 2023 (in thousands) Unvested RSUs and shares of common stock 9,275 6,747 Stock options 849 1,444 Unvested PSAs (1) 1,056 721 Share purchase rights under the ESPP 826 796 Notes (2) 7,626 7,626 Total 19,632 17,334 (1) The number of unvested PSAs is estimated at 100% of the target number of shares granted and excludes unvested PSAs for which performance conditions have not been established as of January 31, 2024 and 2023, as they are not considered outstanding for accounting purposes. For further information refer to Note 11, Stock-Based Compensation. (2) The shares underlying the conversion option in the Notes were not considered in the calculation of diluted net loss per share as the effect would have been antidilutive. Based on the initial conversion price, the entire outstanding principal amount of the Notes as of January 31, 2024 would have been convertible into approximately 7.6 million shares of our common stock, which is reflected in the above table. Conversion notices received through January 31, 2024, have not been material. In connection with the issuance of the Notes, we entered into Capped Calls, which have not been included in the computation of the number of diluted shares outstanding, as their effect would be antidilutive. The Capped Calls are expected to partially offset the potential dilution to our common stock upon any conversion of the Notes.

Business and Summary of Signi_3

Business and Summary of Significant Accounting Policies (Details) - Servers and Networking Equipment - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jan. 31, 2024	Jan. 31, 2024	Jul. 31, 2023
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Useful life	5 years	5 years	4 years
Long Lived Tangible Assets Amortization Period
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decreased depreciation expense	$ 3.2	$ 6.3

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023	Jul. 31, 2023
Concentration Risk [Line Items]
Deferred revenue	$ 1,502.2		$ 1,502.2		$ 1,439.7
Contract with customer, liability, revenue recognized			840.8	$ 603.8
Revenue, remaining performance obligation	3,613		3,613
Accrued sales commissions	$ 24.3		$ 24.3		$ 48
Minimum
Concentration Risk [Line Items]
Contract with customer, term of contract			1 year
Maximum
Concentration Risk [Line Items]
Contract with customer, term of contract			3 years
Transferred Over Time | Product Concentration Risk | Subscription and Support | Revenue Benchmark
Concentration Risk [Line Items]
Concentration risk percentage	97%	97%	97%	97%

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Disaggregation of Revenue [Line Items]
Revenue	$ 524,999	$ 387,598	$ 1,021,702	$ 743,146
Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 524,999	$ 387,598	$ 1,021,702	$ 743,146
Revenue percentage	100%	100%	100%	100%
Revenue Benchmark | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 524,999	$ 387,598	$ 1,021,702	$ 743,146
Revenue percentage	100%	100%	100%	100%
Revenue Benchmark | Customer Concentration Risk | Channel partners
Disaggregation of Revenue [Line Items]
Revenue	$ 480,592	$ 358,165	$ 935,047	$ 687,522
Revenue percentage	92%	92%	92%	93%
Revenue Benchmark | Customer Concentration Risk | Direct customers
Disaggregation of Revenue [Line Items]
Revenue	$ 44,407	$ 29,433	$ 86,655	$ 55,624
Revenue percentage	8%	8%	8%	7%
United States | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 263,970	$ 193,508	$ 511,502	$ 369,023
Revenue percentage	50%	50%	50%	50%
Europe, Middle East and Africa | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 164,009	$ 124,742	$ 321,254	$ 241,749
Revenue percentage	31%	32%	31%	32%
Asia Pacific | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 79,077	$ 57,602	$ 154,157	$ 109,858
Revenue percentage	15%	15%	15%	15%
Other | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 17,943	$ 11,746	$ 34,789	$ 22,516
Revenue percentage	4%	3%	4%	3%

Revenue Recognition - Performan

Revenue Recognition - Performance Obligation (Details)	Jan. 31, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	51%
Recognized transaction price period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	96%
Recognized transaction price period	3 years

Revenue Recognition - Capitaliz

Revenue Recognition - Capitalized Contract Costs (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023	Jul. 31, 2023
Changes in Capitalized Contract Cost [Roll Forward]
Beginning balance	$ 372,803	$ 301,472	$ 375,234	$ 297,002
Capitalization of contract acquisition costs	40,064	37,407	67,744	64,202
Amortization of deferred contract acquisition costs	(31,393)	(23,728)	(61,504)	(46,053)
Ending balance	381,474	315,151	381,474	315,151
Deferred contract acquisition costs, current	125,591		125,591		$ 115,827
Deferred contract acquisition costs, noncurrent	255,883		255,883		259,407
Total deferred contract acquisition costs	$ 381,474	$ 315,151	$ 381,474	$ 315,151	$ 375,234

Cash Equivalents and Short-Te_3

Cash Equivalents and Short-Term Investments - Schedule of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jul. 31, 2023
Cash equivalents:
Amortized Cost	$ 1,269,206	$ 1,130,724
Unrealized Gains	0	0
Unrealized Losses	(54)	(65)
Fair Value	1,269,152	1,130,659
Short-term investments:
Amortized Cost	1,022,948	848,360
Unrealized Gains	1,797	51
Unrealized Losses	(3,527)	(10,385)
Fair Value	1,021,218	838,026
Total cash equivalents and short-term investments, amortized cost	2,292,154	1,979,084
Total cash equivalents and short-term investments, unrealized gains	1,797	51
Total cash equivalents and short-term investments, unrealized losses	(3,581)	(10,450)
Total cash equivalents and short-term investments	2,290,370	1,968,685
U.S. treasury securities
Short-term investments:
Amortized Cost	311,785	175,451
Unrealized Gains	88	0
Unrealized Losses	(532)	(1,875)
Fair Value	311,341	173,576
U.S. government agency securities
Short-term investments:
Amortized Cost	150,437	266,392
Unrealized Gains	109	2
Unrealized Losses	(1,638)	(4,299)
Fair Value	148,908	262,095
Corporate debt securities
Short-term investments:
Amortized Cost	560,726	406,517
Unrealized Gains	1,600	49
Unrealized Losses	(1,357)	(4,211)
Fair Value	560,969	402,355
Money market funds
Cash equivalents:
Amortized Cost	884,888	768,003
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	884,888	768,003
U.S. treasury securities
Cash equivalents:
Amortized Cost	148,846	157,250
Unrealized Gains	0	0
Unrealized Losses	(24)	(30)
Fair Value	148,822	157,220
U.S. government agency securities
Cash equivalents:
Amortized Cost	218,975	166,671
Unrealized Gains	0	0
Unrealized Losses	(30)	(35)
Fair Value	218,945	166,636
Corporate debt securities
Cash equivalents:
Amortized Cost	16,497	38,800
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	$ 16,497	$ 38,800

Cash Equivalents and Short-Te_4

Cash Equivalents and Short-Term Investments - Schedule of Maturities (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jul. 31, 2023
Amortized Cost
Due within one year	$ 575,536
Due between one to three years	447,412
Amortized Cost	1,022,948	$ 848,360
Fair Value
Due within one year	572,868
Due between one to three years	448,350
Fair Value	$ 1,021,218	$ 838,026

Cash Equivalents and Short-Te_5

Cash Equivalents and Short-Term Investments - Schedule of Unrealized Position (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jul. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	$ 467,514	$ 525,638
Less than 12 months, unrealized losses	(1,065)	(4,201)
Greater than 12 months, fair value	103,760	214,129
Greater than 12 months, unrealized losses	(2,462)	(6,184)
Total fair value	571,274	739,767
Total unrealized losses	(3,527)	(10,385)
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	242,238	173,576
Less than 12 months, unrealized losses	(532)	(1,875)
Greater than 12 months, fair value	0	0
Greater than 12 months, unrealized losses	0	0
Total fair value	242,238	173,576
Total unrealized losses	(532)	(1,875)
U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	68,954	119,558
Less than 12 months, unrealized losses	(57)	(292)
Greater than 12 months, fair value	53,831	131,530
Greater than 12 months, unrealized losses	(1,581)	(4,007)
Total fair value	122,785	251,088
Total unrealized losses	(1,638)	(4,299)
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	156,322	232,504
Less than 12 months, unrealized losses	(476)	(2,034)
Greater than 12 months, fair value	49,929	82,599
Greater than 12 months, unrealized losses	(881)	(2,177)
Total fair value	206,251	315,103
Total unrealized losses	$ (1,357)	$ (4,211)

Cash Equivalents and Short-Te_6

Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($) $ in Millions	Jan. 31, 2024	Jul. 31, 2023
Cash and Cash Equivalents [Abstract]
Accrued interest receivable	$ 10	$ 7.2
Investment carrying value	$ 9.8	$ 7.8

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jul. 31, 2023
Cash equivalents:
Fair Value	$ 1,269,152	$ 1,130,659
Short-term investments:
Short-term investments	1,021,218	838,026
Total cash equivalents and short-term investments	2,290,370	1,968,685
Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	1,269,152	1,130,659
Short-term investments:
Short-term investments	1,021,218	838,026
Total cash equivalents and short-term investments	2,290,370	1,968,685
Fair Value, Measurements, Recurring | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	5,627	12,581
Foreign currency contract assets-noncurrent	763	2,264
Foreign currency contracts liabilities-current	3,631	1,452
Foreign currency contracts liabilities-noncurrent	918	669
Non-designated derivative instruments:
Foreign currency contracts assets-current	5,627	12,581
Foreign currency contracts liabilities-current	3,631	1,452
Fair Value, Measurements, Recurring | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	1,269	2,061
Foreign currency contracts liabilities-current	2,185	465
Non-designated derivative instruments:
Foreign currency contracts assets-current	1,269	2,061
Foreign currency contracts liabilities-current	2,185	465
Fair Value, Measurements, Recurring | Interest rate contracts assets | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-noncurrent	607
Foreign currency contracts liabilities-current	3,945	6,439
Foreign currency contracts liabilities-noncurrent		1,588
Non-designated derivative instruments:
Foreign currency contracts liabilities-current	3,945	6,439
Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	884,888	768,003
Short-term investments:
Short-term investments	0	0
Total cash equivalents and short-term investments	884,888	768,003
Fair Value, Measurements, Recurring | Level I | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contract assets-noncurrent	0	0
Foreign currency contracts liabilities-current	0	0
Foreign currency contracts liabilities-noncurrent	0	0
Non-designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level I | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Non-designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level I | Interest rate contracts assets | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-noncurrent	0
Foreign currency contracts liabilities-current	0	0
Foreign currency contracts liabilities-noncurrent		0
Non-designated derivative instruments:
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	384,264	362,656
Short-term investments:
Short-term investments	1,021,218	838,026
Total cash equivalents and short-term investments	1,405,482	1,200,682
Fair Value, Measurements, Recurring | Level II | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	5,627	12,581
Foreign currency contract assets-noncurrent	763	2,264
Foreign currency contracts liabilities-current	3,631	1,452
Foreign currency contracts liabilities-noncurrent	918	669
Non-designated derivative instruments:
Foreign currency contracts assets-current	5,627	12,581
Foreign currency contracts liabilities-current	3,631	1,452
Fair Value, Measurements, Recurring | Level II | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	1,269	2,061
Foreign currency contracts liabilities-current	2,185	465
Non-designated derivative instruments:
Foreign currency contracts assets-current	1,269	2,061
Foreign currency contracts liabilities-current	2,185	465
Fair Value, Measurements, Recurring | Level II | Interest rate contracts assets | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-noncurrent	607
Foreign currency contracts liabilities-current	3,945	6,439
Foreign currency contracts liabilities-noncurrent		1,588
Non-designated derivative instruments:
Foreign currency contracts liabilities-current	3,945	6,439
Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
Short-term investments:
Short-term investments	0	0
Total cash equivalents and short-term investments	0	0
Fair Value, Measurements, Recurring | Level III | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contract assets-noncurrent	0	0
Foreign currency contracts liabilities-current	0	0
Foreign currency contracts liabilities-noncurrent	0	0
Non-designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level III | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Non-designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level III | Interest rate contracts assets | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-noncurrent	0
Foreign currency contracts liabilities-current	0	0
Foreign currency contracts liabilities-noncurrent		0
Non-designated derivative instruments:
Foreign currency contracts liabilities-current	0	0
U.S. treasury securities
Short-term investments:
Short-term investments	311,341	173,576
U.S. treasury securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	311,341	173,576
U.S. treasury securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
U.S. treasury securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	311,341	173,576
U.S. treasury securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
U.S. government agency securities
Short-term investments:
Short-term investments	148,908	262,095
U.S. government agency securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	148,908	262,095
U.S. government agency securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
U.S. government agency securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	148,908	262,095
U.S. government agency securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
Corporate debt securities
Short-term investments:
Short-term investments	560,969	402,355
Corporate debt securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	560,969	402,355
Corporate debt securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
Corporate debt securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	560,969	402,355
Corporate debt securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
Money market funds
Cash equivalents:
Fair Value	884,888	768,003
Money market funds | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	884,888	768,003
Money market funds | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	884,888	768,003
Money market funds | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	0	0
Money market funds | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
U.S. treasury securities
Cash equivalents:
Fair Value	148,822	157,220
U.S. treasury securities | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	148,822	157,220
U.S. treasury securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	0	0
U.S. treasury securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	148,822	157,220
U.S. treasury securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
U.S. government agency securities
Cash equivalents:
Fair Value	218,945	166,636
U.S. government agency securities | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	218,945	166,636
U.S. government agency securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	0	0
U.S. government agency securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	218,945	166,636
U.S. government agency securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
Corporate debt securities
Cash equivalents:
Fair Value	16,497	38,800
Corporate debt securities | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	16,497	38,800
Corporate debt securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	0	0
Corporate debt securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	16,497	38,800
Corporate debt securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	$ 0	$ 0

Property and Equipment and Pu_3

Property and Equipment and Purchased Intangible Assets - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jul. 31, 2023
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 502,856	$ 418,779
Less: Accumulated depreciation and amortization	(208,361)	(176,424)
Total property and equipment, net	294,495	242,355
Hosting equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	336,678	280,851
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	149,805	120,877
Computers and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	6,060	7,107
Purchased software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	1,102	1,311
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	933	1,025
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 8,278	$ 7,608

Property and Equipment and Pu_4

Property and Equipment and Purchased Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023	Jul. 31, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Historical cost	$ 59,816		$ 59,816		$ 57,016
Accumulated amortization	37,276		37,276		31,157
Depreciation and amortization expense	15,400	$ 13,400	29,361	$ 25,241
Capitalization of development costs of software for internal-use	140,432	109,738	269,570	214,911
Internet Protocol Addresses and Source Codes
Acquired Finite-Lived Intangible Assets [Line Items]
Historical cost	12,400		12,400		8,600
Accumulated amortization	$ 2,200		$ 2,200		$ 1,600
Internet Protocol Addresses and Source Codes | Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	5 years		5 years
Internet Protocol Addresses and Source Codes | Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	10 years		10 years
Capitalized internal-use software
Acquired Finite-Lived Intangible Assets [Line Items]
Capitalization of development costs of software for internal-use	$ 3,100	$ 2,000	$ 5,900	$ 3,700

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Thousands		6 Months Ended
	Aug. 31, 2023	Jan. 31, 2024	Jul. 31, 2023
Business Acquisition [Line Items]
Goodwill		$ 92,415	$ 89,192
Developed technology, estimated useful life		2 years 10 months 24 days
Developed technology
Business Acquisition [Line Items]
Developed technology, estimated useful life		3 years
Securelyshare Software Private Ltd
Business Acquisition [Line Items]
Cash consideration	$ 5,300
Contingent consideration	$ 800
Contingent consideration term	18 months
Goodwill	$ 3,200
Deferred tax liability	700
Securelyshare Software Private Ltd | Developed technology
Business Acquisition [Line Items]
Finite-lived intangibles	$ 2,800
Developed technology, estimated useful life	5 years

Goodwill and Acquired Intangi_3

Goodwill and Acquired Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023	Jul. 31, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 92,415		$ 92,415		$ 89,192
Developed technology, estimated useful life			2 years 10 months 24 days
Amortization expense of acquired intangible assets	3,100	$ 2,600	$ 6,119	$ 5,103
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Developed technology, estimated useful life			3 years
Amortization expense of acquired intangible assets			$ 5,667
Securelyshare | Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangibles	$ 2,800		$ 2,800
Developed technology, estimated useful life	5 years		5 years

Goodwill and Acquired Intangi_4

Goodwill and Acquired Intangible Assets - Schedule of Acquired Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023	Jul. 31, 2023
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance			$ 57,016
Additions			2,800
Intangible Assets, Gross, ending balance	$ 59,816		59,816
Accumulated Amortization, beginning balance			(31,157)
Amortization Expense	(3,100)	$ (2,600)	(6,119)	$ (5,103)
Accumulated Amortization, ending balance	(37,276)		(37,276)
Total	22,540		$ 22,540		$ 25,859
Weighted Average Remaining Useful life			2 years 10 months 24 days
Developed technology
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance			$ 53,456
Additions			2,800
Intangible Assets, Gross, ending balance	56,256		56,256
Accumulated Amortization, beginning balance			(29,259)
Amortization Expense			(5,667)
Accumulated Amortization, ending balance	(34,926)		(34,926)
Total	21,330		$ 21,330		24,197
Weighted Average Remaining Useful life			3 years
Customer relationships
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance			$ 3,560
Additions			0
Intangible Assets, Gross, ending balance	3,560		3,560
Accumulated Amortization, beginning balance			(1,898)
Amortization Expense			(452)
Accumulated Amortization, ending balance	(2,350)		(2,350)
Total	$ 1,210		$ 1,210		$ 1,662
Weighted Average Remaining Useful life			2 years

Goodwill and Acquired Intangi_5

Goodwill and Acquired Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
2024 (remaining six months)	$ 5,714
2025	6,825
2026	5,812
2027	2,988
2028	1,155
2029	46
Total	$ 22,540	$ 25,859

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($) $ in Thousands	6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jul. 31, 2023
Derivative [Line Items]
Unrealized losses related to our cash flow hedges	$ 1,200
Hedge accounting fair value adjustments	(3,409)		$ (8,306)
Long-term Debt
Derivative [Line Items]
Hedged liability, fair value hedge	498,500
Foreign currency contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional amount	230,600		182,900
Foreign currency contracts | Designated as Hedging Instrument
Derivative [Line Items]
Notional amount	487,600		$ 457,600
Interest Rate Swap
Derivative [Line Items]
Notional amount	$ 500,000
Minimum | Foreign currency contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Term of derivative	1 month
Maximum
Derivative [Line Items]
Term of derivative	21 months
Maximum | Foreign currency contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Term of derivative		4 months

Derivative Instruments - Schedu

Derivative Instruments - Schedule of Changes of AOCI Related to our Cash Flow Hedges (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 807,525	$ 431,275	$ 725,112	$ 573,300
Net unrealized gains (losses) recognized in accumulated other comprehensive income	7,353	24,019	(7,783)	9,980
Losses (gains) reclassified from AOCI into the condensed consolidated statement of operations	(1,611)	4,267	(2,265)	8,980
Ending balance	958,856	528,657	958,856	528,657
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(6,853)	(23,070)	8,937	(13,744)
Ending balance	$ (1,111)	$ 5,216	$ (1,111)	$ 5,216

Derivative Instruments - Sche_2

Derivative Instruments - Schedule of Cash Flow Hedges on our Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ (1,611)	$ 4,267	$ (2,265)	$ 8,980
Cost of revenue
Derivative Instruments, Gain (Loss) [Line Items]
Total	(321)	706	(497)	1,413
Sales and marketing
Derivative Instruments, Gain (Loss) [Line Items]
Total	(1,029)	2,757	(1,324)	6,053
Research and development
Derivative Instruments, Gain (Loss) [Line Items]
Total	(123)	583	(215)	1,047
General and administrative
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ (138)	$ 221	$ (229)	$ 467

Derivative Instruments - Sche_3

Derivative Instruments - Schedule of Derivative Instruments Designated as Fair Value Hedges (Details) - Interest rate swaps: - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jan. 31, 2024	Jan. 31, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	$ 6,007	$ 4,897
Derivatives designated as hedging instruments	(5,783)	(4,689)
Total	$ 224	$ 208

Convertible Senior Notes - Narr

Convertible Senior Notes - Narrative (Details) $ / shares in Units, $ in Millions	Jun. 25, 2020 USD ($) trading_day $ / shares	Jan. 31, 2024 USD ($)	Jul. 31, 2023 USD ($)
Debt Instrument [Line Items]
Proceeds from debt issuance	$ 1,130.5
Fair value of notes		$ 1,843.3	$ 1,411.4
Initial strike price (in dollars per share) | $ / shares	$ 150.80
Initial cap price (in dollars per shares) | $ / shares	$ 246.76
Convertible Senior Notes Due 2025
Debt Instrument [Line Items]
Principal amount	$ 1,150
Interest rate	0.125%
Threshold percentage of share price that triggers conversion	130%
Threshold trading days | trading_day	20
Threshold consecutive trading days | trading_day	30
Convertible Senior Notes, $150 million
Debt Instrument [Line Items]
Principal amount	$ 150

Convertible Senior Notes - Carr

Convertible Senior Notes - Carrying Amounts (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jul. 31, 2023
Convertible Debt [Abstract]
Principal amount	$ 1,149,993	$ 1,149,993
Unamortized debt issuance costs	5,573	7,528
Hedge accounting fair value adjustments	3,409	8,306
Total	$ 1,141,011	$ 1,134,159

Convertible Senior Notes - Inte

Convertible Senior Notes - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Debt Disclosure [Abstract]
Contractual interest expense	$ 359	$ 360	$ 718	$ 719
Amortization of debt issuance costs	978	973	1,955	1,945
Total	$ 1,337	$ 1,333	$ 2,673	$ 2,664

Commitments and Contingencies (

Commitments and Contingencies (Details) - Third-Party Service Agreement $ in Millions	6 Months Ended
	Jan. 31, 2024 USD ($)
Loss Contingencies [Line Items]
Purchase obligation	$ 100
Purchase commitment, period	5 years

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended		12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jul. 31, 2023
Outstanding Stock Options
Beginning balance (in shares)	1,267,000
Granted (in shares)	50,000	0
Exercised (in shares)	(468,000)
Canceled, forfeited or expired (in shares)	0
Ending balance (in shares)	849,000		1,267,000
Exercisable and expected to vest (in shares)	749,000		1,210,000
Weighted-Average Exercise Price
Beginning balance (in dollars per share)	$ 18.54
Granted (in dollars per share)	198.03
Exercised (in dollars per share)	8.23
Canceled, forfeited or expired (in dollars per share)	0
Ending balance (in dollars per share)	34.80		$ 18.54
Exercisable and expected to vest (in dollars per share)	$ 16		$ 12.82
Weighted-Average Remaining Contractual Term (in years)
Options outstanding, weighted average remaining contractual term	1 year 9 months 18 days		2 years 1 month 6 days
Exercisable and expected to vest, weighted average remaining contractual term	9 months 18 days		1 year 9 months 18 days
Options outstanding, aggregate intrinsic value	$ 170,500		$ 179,678
Exercised, aggregate intrinsic value	87,640	$ 30,000
Exercisable and expected to vest, aggregate intrinsic value	$ 164,484		$ 178,616

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Oct. 31, 2022	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023	Jul. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercised, aggregate intrinsic value				$ 87,640	$ 30,000
Weighted average grant date fair value (in dollars per share)				$ 198.03
Granted (in shares)				50,000	0
Weighted-average purchase price per share (in dollars per share)		$ 104.69		$ 104.69
Reversal of stock-based compensation		$ 140,432	$ 109,738	$ 269,570	$ 214,911
Capitalized stock-based compensation		$ 6,400	$ 4,300	11,200	$ 8,300
President
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reversal of stock-based compensation	$ (9,900)
Employee Stock | 2018 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued (in shares)		200,000
Cash proceeds from the issuance of common stock		$ 18,400
Accrued compensation		$ 9,700		$ 9,700		$ 7,400

Stock-Based Compensation - Valu

Stock-Based Compensation - Valuation Assumptions (Details)	6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 years
Expected stock price volatility	59.50%
Risk-free interest rate	4.20%
Dividend yield	0%
Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected stock price volatility, minimum	42.50%	62.40%
Expected stock price volatility, maximum	64.80%	75.90%
Risk-free interest rate, minimum	4.40%	4.20%
Risk-free interest rate, maximum	5.30%	4.70%
Dividend yield	0%	0%
Employee Stock | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 months	6 months
Employee Stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	2 years	2 years

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of RSU and PSA Activity (Details) - Restricted Stock Units and Performance Stock Awards $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended
	Jan. 31, 2024 USD ($) $ / shares shares
Underlying Shares
Beginning balance (in shares) | shares	9,351
Granted (in shares) | shares	3,501
Vested (in shares) | shares	(1,945)
Canceled or forfeited (in shares) | shares	(654)
Ending balance (in shares) | shares	10,253
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 139.95
Granted (in dollars per share) | $ / shares	173.32
Vested (in dollars per share) | $ / shares	133.52
Canceled or forfeited (in shares) | $ / shares	156.13
Ending balance (in dollars per share) | $ / shares	$ 151.53
Aggregate Intrinsic Value
Beginning balance | $	$ 1,499,714
Vested | $	366,164
Ending balance | $	$ 2,416,430

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 140,432	$ 109,738	$ 269,570	$ 214,911
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	13,029	9,410	25,613	17,842
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	63,044	54,213	119,674	107,848
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	42,872	29,005	83,065	53,536
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 21,487	$ 17,110	$ 41,218	$ 35,685

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 7,964	$ 3,692	$ 16,961	$ 8,438

Net Loss Per Share - Net Loss P

Net Loss Per Share - Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Earnings Per Share [Abstract]
Net loss, basic	$ (28,469)	$ (57,453)	$ (61,952)	$ (125,615)
Net loss, diluted	$ (28,469)	$ (57,453)	$ (61,952)	$ (125,615)
Weighted-average shares used in computing net loss per share, basic (in shares)	148,951	144,511	148,287	144,001
Weighted-average shares used in computing net loss per share, diluted (in shares)	148,951	144,511	148,287	144,001
Net loss per share, basic (in dollars per share)	$ (0.19)	$ (0.40)	$ (0.42)	$ (0.87)
Net loss per share, diluted (in dollars per share)	$ (0.19)	$ (0.40)	$ (0.42)	$ (0.87)

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities Excluded from Computation (Details) - shares shares in Thousands	6 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	19,632	17,334
Number of shares if notes converted (in shares)	7,600
Unvested RSUs and shares of common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	9,275	6,747
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	849	1,444
Unvested PSAs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,056	721
Number of unvested PSAs as a percentage of target	100%	100%
Share purchase rights under the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	826	796
Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	7,626	7,626

Uncategorized Items - zs-202401

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2020-06 [Member]